Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
22.3 USD | 0.00% | -0.27% | +509.29% |
09/05 | Landos Biopharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
02/04 | North American Morning Briefing : Stocks Seen -2- | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+509.29% | 6.97Cr | |
+33.37% | 5.08TCr | |
+1.55% | 4.28TCr | |
+49.00% | 4.2TCr | |
-4.22% | 2.95TCr | |
+11.57% | 2.61TCr | |
-21.00% | 1.91TCr | |
+7.36% | 1.31TCr | |
+28.30% | 1.22TCr | |
+23.80% | 1.21TCr |
- Stock Market
- Equities
- LABP Stock
- News Landos Biopharma, Inc.
- Craig-Hallum Adjusts Landos Biopharma's Price Target to $29.50 From $45, Reiterates Buy Rating